Biotech · Private company · Manassas, VA, US
Serpin Pharma, LLC
Track this companyFree. Adds Serpin Pharma, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards2
- A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral NeuropathyFiscal year 2025 · $625.4KNIH RePORTER 5R44CA268700-03 · fetched Nov 12, 2026
- A Novel LRP1 Agonist, SP16, as a Therapeutic Treatment in Preventing Chemotherapy-Induced Peripheral NeuropathyFiscal year 2024 · $838.7KNIH RePORTER 2R44CA268700-02A1 · fetched Nov 12, 2026